The GRECCO-19 Randomized Clinical Trial "The hypothesis-generating findings of this study suggest a role for colchicine in the treatment of patients with coronavirus disease 2019" 2/5 https://t.co/0m1Btidjsm https://t.co/4wlAC2K3cl
RT @colinbro: @DrAndrewHill Suspected this since June from research in Greece: https://t.co/qw42N5XCMN #NotInventedHere Seems "Anti-inflam…
@mikejohansenmd There was this ages ago and RECOVERY has recruited thousands. https://t.co/1CZ4j9dkua
@matpel22 @BarbaTruc20 @DoucetSt @jctardif_mhi @ICMtl Une autre petite randomisée, mais open-label, ici: https://t.co/rNtZseL89M
@lebon80 @MarianneleMag @andrebercoff @ReinfoCovidOff @24hPujadas @PascalPraud @HAS_sante @hcsp_fr Un RCT Grec sur + de 100 malades a eu des résultats comparables, sans pb d effet secondaire grave... https://t.co/9zqmehYWnv https://t.co/kJR6GvSMKC
@DrAndrewHill Suspected this since June from research in Greece: https://t.co/qw42N5XCMN #NotInventedHere Seems "Anti-inflammatory" term does a lot of heavy lifting: effective Rx from specific biologicals like #Baricitinib, non-specific colchicine or NSAI
@andrew_croxford Lots of questions undoubtedly when we see a press release without formal data. Worth noting Colchicine has form here; https://t.co/rZedUvqw44
@charcharcatpig @trishgreenhalgh Suspected this since June from research in Greece: https://t.co/qw42N5XCMN #NotInventedHere Seems "Anti-inflammatory" term does a lot of heavy lifting: effective Rx from specific biologicals like #Baricitinib, non-specific
@andrew_croxford this is was obvious: https://t.co/SOOaQw5CGk, https://t.co/gMzct9M23t
Voir également : https://t.co/QhLhVaDHco Ce médicament a été intégré fin novembre à l'essai Recovery au Royaume-Uni.
@djc795 @mikejohansenmd @DrToddLee @BinitaShahMD @ADAlthousePhD @MaartenvSmeden Also this paper from back in June! (which I totally missed at the time) https://t.co/Iy1NEiMMLI
RT @AaronOtsuka: @snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
RT @AaronOtsuka: @snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
RT @AaronOtsuka: @snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
RT @AaronOtsuka: @snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
#コロナはただの風邪
RT @AaronOtsuka: @snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
@snake_eyes11_11 ギリシャの研究でコルヒチンが効くと既に仮説として提案されているようです。 https://t.co/lBHBm2xQpp
RT @Yamamoto0509: 新型コロナウイルス感染症へのコルヒチン試験のプロトコール@ギリシャ コルヒチン開始用量を1.5mgとし60分後に0.5mgを追加投与し、その後は1日2回(体重が60kg未満なら1回)、0.5mgを退院まで、または最長21日間投与した。 症状悪…
RT @Yamamoto0509: 新型コロナウイルス感染症へのコルヒチン試験のプロトコール@ギリシャ コルヒチン開始用量を1.5mgとし60分後に0.5mgを追加投与し、その後は1日2回(体重が60kg未満なら1回)、0.5mgを退院まで、または最長21日間投与した。 症状悪…
RT @Yamamoto0509: 新型コロナウイルス感染症へのコルヒチン試験のプロトコール@ギリシャ コルヒチン開始用量を1.5mgとし60分後に0.5mgを追加投与し、その後は1日2回(体重が60kg未満なら1回)、0.5mgを退院まで、または最長21日間投与した。 症状悪…
新型コロナウイルス感染症へのコルヒチン試験のプロトコール@ギリシャ コルヒチン開始用量を1.5mgとし60分後に0.5mgを追加投与し、その後は1日2回(体重が60kg未満なら1回)、0.5mgを退院まで、または最長21日間投与した。 症状悪化が減少したが、データに差は無かったと。 https://t.co/KW6233ot5u
@punitbansal14 #Colchicine exert its actions mainly through the inhibition of microtubule polymerization & leucocyte infiltration, but a significant part of colchicine’s anti-inflammatory action is attributed to inhibition of the NLRP3 inflammasome #GR
@punitbansal14 #Colchicine inhibits NLRP3 inflammasome on 2 levels: by inhibiting P2X7 receptor activation and adaptor ASC polymerization, inhibiting interaction btwn pyrin-like domains, & by suppressing mitochondrial transport https://t.co/1UqU60NdPz
RT @dvrachatis: Great news! Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial #Recoverytrial #COVID1…
RT @dvrachatis: Great news! Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial #Recoverytrial #COVID1…
RT @dvrachatis: Great news! Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial #Recoverytrial #COVID1…
Great news! Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial #Recoverytrial #COVID19. https://t.co/n1i9ThDcbe happy for this, since #GRECCO19 (https://t.co/Aoyc8fgDGc) was the first to support its use in COVID-19.
Colchicine added 👍 Links to studies related to colchicine vs COVID-19 https://t.co/fkXjeecCHt https://t.co/H1QnG17pYu https://t.co/q80TIT7lXq https://t.co/4qcsjuSOY1 https://t.co/zuMHWKkXUT https://t.co/Zbp5LJRaj8
RT @florindanpopesq: #Colchicine inhibits NLRP3 inflammasome 3 on 2 levels: by inhibiting P2X7 receptor activation and adaptor ASC polymeri…
@DrNeilStone More chance of colchicine working: https://t.co/1CZ4j9uVSK
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
@DrMiniDey @RheumNow Full paper is also out https://t.co/yTl42l6n2K. First RCT on the field was https://t.co/Aoyc8fgDGc
Interesante artículo. Con muchas limitaciones, como todos en terapia COVID. https://t.co/gKJlJHRWjn
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hosp… https://t.co/DCsYRf1nPv
RT @dvrachatis: After #GRECCO_19 https://t.co/Aoyc8fyexK another encouraging study on #colchicine in #COVID patients showing survival benef…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
RT @kharaguchi: 1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。…
1) 経口DNAワクチンTRL-Spikeの臨床試験がスタート 2) ミンク間での感染伝播で出現した変異株のヒト感染が確認 3) 日本:塩野義製薬のワクチンの第1相試験を年内に国内で開始8) アメリカ:1日の新規感染者10万人、死亡者1100人。入院患者は現在5万人https://t.co/YcNIPpJsas
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
RT @influenzer3: Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalize…
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 https://t.co/vH2TMxjgmG
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
Colchicine (the active ingredient of 'Suranjan') given to symptomatic cases of #Covid19 resulted in faster recovery and reduction in mortality
Gout meds
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT julienpotet https://t.co/1ANsCL4PQZ "RT __ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/YPdmWuw2he…"
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
L'efficacité de la colchicine sur les patients hospitalisés COVID se confirme.
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
Colchine/colcorona/COVID-19 ⬇️
RT @__ice9: At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8…
At least 6 studies on colchicine for hospitalized COVID-19, all successful. Includes 3 RCTs-- Greece: https://t.co/L0IVPsvjH8 Large reduction in mortality and ICU admissions. Brazil: https://t.co/3EdYV8RcKN Faster recovery. Iran: https://t.co/1tsGeZT5P
RT @dvrachatis: One more study (online 27-Oct), from #USA, https://t.co/7WSWRHYWU8 shows benefit of #colchicine in #COVID19. Adds up to #G…
One more study (online 27-Oct), from #USA, https://t.co/7WSWRHYWU8 shows benefit of #colchicine in #COVID19. Adds up to #GRECCO19 https://t.co/c4tijQFatB, the study by Scarsi et al. https://t.co/Z7z0C1PxrI, the study by Brunetti et al. https://t.co/DKanTI
@jameshorowitzmd @PERTConsortium @2Scottish @YogenKanthi Apart from that, NETs are involved: https://t.co/rPUoQ78Rzt Anakinra can address that: https://t.co/oRNxdh4XjR Colchicine also reduces NETosis, with excellent results in a mid-sized RCT: https://t.
@drpablocorral @colcovidtrial #Colchicine has already a positive RCT published #GRECCO19 https://t.co/Aoyc8fgDGc, 2nd the study by Scarsi et al. https://t.co/e5vgYlXPGS, 3rd a pre-print from Brazil https://t.co/UkBDTprOqS. and 4th a study from NJ (USA) h
@SABOURETCardio @Docjoshsoc @HeartOTXHeartMD I’m curious if you have any thoughts about colchicine (the old new miracle drug)? There’s promising results from ~300 covid patients in 4 studies/rct, but results from the 6,000 person colcorona is now delayed
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases. https://t.co/HCeeGtAxaA
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases.
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases.
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases.
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases.
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases. https://t.co/HCeeGtAxaA
RT @__ice9: Colchicine studies compendium. Still impressive results in hospitalized cases.
RT @dvrachatis: One more study, from #USA, https://t.co/yTl42l6n2K, shows benefit of #colchicine in #COVID19. These data add up to #GRECCO1…
RT @dvrachatis: One more study, from #USA, https://t.co/yTl42l6n2K, shows benefit of #colchicine in #COVID19. These data add up to #GRECCO1…